Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.051 |
---|---|
High | 0.0694 |
Low | 0.051 |
Bid | 0.051 |
Offer | 0.0694 |
Previous close | 0.0696 |
Average volume | 133.23k |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Nov 22 2024 10:30 GMT.
More ▼
Press releases
- Immunovia presents model-development study results at meeting of the Collaborative Group of the Americas--Inherited Gastrointestinal Cancers
- Invitation to Immunovia's Q3 presentation
- Immunovia presents data from model development study at meeting of the PRECEDE pancreatic cancer research consortium
- Immunovia has successfully acquired all blood samples required to clinically validate its next-generation test for pancreatic cancer
- Immunovia completes analytical validation of its next-generation pancreatic cancer test
- Change in number of shares and votes in Immunovia AB (publ)
- Immunovia presents data from model development study at 2024 AACR Advances in Pancreatic Cancer medical conference
More ▼